par Van Der Auwera, Philippe
Référence Médecine et maladies infectieuses, 23, SPEC. ISS. SEPT., page (60-66)
Publication Publié, 1993
Article révisé par les pairs
Résumé : The current epidemiology of febrile episodes in neutropenic patients is reviewed as well as the consensus regarding their empiric therapy. The contribution of qd administration of an aminoglycoside (amikacin) combined with ceftriaxone is reviewed emphasizing the problems of interpretation of efficacy nephrotoxicity and ototoxicity. The potential benefit of single daily dosing is significant and must be balanced with the current clinical data.